TZIELD
TZIELD
Approved
DIN Number
02557347
Drug Class
Human
Market Date
N/A
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02557347
AIG Number0166824001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A10XX01 TEPLIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification68:20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TEPLIZUMABActive
Strength: 2 MG / 2 ML
Monograph: TEPLIZUMAB